documents: FDA-2003-N-0196-0003

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2003-N-0196-0003 FDA FDA-2003-N-0196 Reference 5 FDA's Evaluation and Comments on the TEA for Encacamene Division of OTC Drug Products Memorandum to Dockets Management, July 14, 2003 re Public Admlnistratlve File for Over-the-Counter Drug Products; Safety and Efficacy, Volume No. 352-01 - Background Supporting & Related Material BKG-Background Material 2003-07-30T04:00:00Z 2003 7     2014-06-09T20:52:46Z   0 0 090000648048b554

Links from other tables